Results 271 to 280 of about 128,678 (309)

Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten. [PDF]

open access: yesJACC Heart Fail
Reza N   +9 more
europepmc   +1 more source

Echocardiographic Mitral Valve Fibroelastoma in a Patient With Hypertrophic Cardiomyopathy. [PDF]

open access: yesJACC Case Rep
Le Q   +6 more
europepmc   +1 more source

Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes

open access: yesNature Communications
Bradley A. Maron   +14 more
doaj   +1 more source

Hypertrophic cardiomyopathy

The Lancet, 2013
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant, cardiovascular disorder that carries the risk of sudden cardiac death. The prevalence of HCM is 1:500 persons. The purpose of this article is to provide an overview of the pathophysiology, symptoms, complications, diagnostic testing, and treatment.
Angelos G, Rigopoulos, Hubert, Seggewiss
  +9 more sources

Hypertrophic Cardiomyopathy

Current Problems in Cardiology, 2004
Abstract The clinical definition of hypertrophic cardiomyopathy is left ventricular hypertrophy in the absence of other causes of left ventricular hypertrophy. The size and volume of the left ventricle are usually normal or smaller. Most cases are familial disease with autosomal dominant inheritance.
Steve R, Ommen, Rick A, Nishimura
openaire   +5 more sources

Hypertrophic Cardiomyopathy

Cardiology Clinics, 1988
Hypertrophic cardiomyopathy is a diverse clinical and pathophysiologic disorder of unknown cause that principally involves the left ventricle and is manifested as asymmetric or concentric hypertrophy. If asymmetric, the hypertrophy is usually greatest in the ventricular septum, but variations occur in which the hypertrophy may be maximal at the mid ...
Z, Sasson, H, Rakowski, E D, Wigle
openaire   +2 more sources

Home - About - Disclaimer - Privacy